Back to DNLI

ADAR1 Capital Management, LLC → DNLI

ADAR1 Capital Management, LLC DNLI Position History

Denali Therapeutics Inc. • Healthcare

Quarters held
5
Latest value
$42.8M
Q3 2026
Peak value
$42.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$860K
Q4 2025$860K
Q1 2026$35.9M
Q2 2026$26.5M
Q3 2026$42.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$42.8M2.07M——
Q2 2026$26.5M1.03M——
Q1 2026$35.9M1.87M——
Q4 2025$860K52.1K——
Q4 2025$860K52.1K——

Other funds holding DNLI

Other ADAR1 Capital Management, LLC positions

AAVXF

ABIVAX SA

$240.5M
AAVXF

ABIVAX SA

$203.1M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$155.2M
SPY

STATE STR SPDR S&P 500 ETF T

$135.5M
PB

PROTAGONIST THERAPEUTICS INC

$134M
PB

PROTAGONIST THERAPEUTICS INC

$117.8M